EBMT 2017 - 43rd Annual Meeting of the European Group for Bone and Marrow Transplantation
Mar 26 - Mar 29, 2017 | MarseilleFrance
LARVOL is not affiliated with 43rd Annual Meeting of the European Group for Bone and Marrow Transplantation and all trademarks, logos, and brand names are property of their respective owners
Showing 17 abstracts linked to Trials
Introduction of the HATCHY study: A Phase III, multicenter, randomised controlled study to compare safety and efficacy of a haploidentical HSCT and adjunctive treatment with ATIR101 with post-transplant cyclophosphamide in patients with a hematologic malignancies
FEASIBILITY AND SAFETY OF ALLOGENEIC EX VIVO ACTIVATED-NK CELL INFUSION AFTER MATCHED RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A PROSPECTIVE PHASE I TRIAL
2-year results of prospective trial of risk-adapted graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide in related, unrelated and haploidentical stem cell transplantations
10% DMSO in cryoprotective mixture may be reduced to 5% without negative impact on hematopoietic engraftment. Final results of prospective, randomized trial.
Feasibility, safety, rapid production and efficacy of institution-produced CD19 CAR T cells in refractory B cell malignancies in Israel
MICROENGRAFTING HLA-PARTIALLY MATCHED MOBILIZED CELLULAR THERAPY (MICROTRANSPLANTATION) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODISPLASTIC SYNDROMES.
ApoGraft, a Negative Functional Selection of Mature T-Cells by Short Ex-Vivo Exposure of Mobilized Peripheral Blood Graft to Fas Ligand: A Novel Technology for GVHD Prevention
GVHD and circulating endothelial cells: it takes two to tango
In vivo effects of Nilotinib on lymphocyte subpopulation and function following allogeneic stem cell transplantation.
Significant Improvement of QoL by using ATG as part of the conditioning regimen followed by HLA-identical peripheral stem cell transplantation in acute leukemia patients. Results from a prospective, randomized phase III study ( ATGFamilyStudy)
Successful haplo-identical stem cell transplant after αβTCR+ depletion in a patient with Interferon gamma receptor 1 deficiency
Outcome of HTLV-1 associated adult T cell leukemia/lymphoma (ATL) w/o allo-HSCT with kinetic monitoring of proviral DNA load in an endemic area in the southeast of China: a consecutive study over 20 years
Aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: intensive immunosuppression and eculizumab treatment. A retrospective analysis from two reference centers.
An exploratory, open-label study to evaluate the safety and feasibility of ATIR201, a T-lymphocyte enriched leukocyte preparation depleted ex vivo of host alloreactive T-cells (using photodynamic treatment), as adjuvant treatment to a T-cell depleted haploidentical hematopoietic stem cell transplantation in patients with beta-thalassemia major
G-CSF primed HLA haploidentical transplantation from maternal or collateral donor using ATG plus reduced dose of posttransplantation cyclophosphamide: Results of a phase II prospective trial